Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Coronavirus disease 2019 (COVID-19) is a serious viral disease caused by SARS-CoV-2, associated with high morbidity and mortality, and represents a significant public health crisis worldwide. Despite recent efforts for developing novel antiviral agents, no specific drugs are approved for the management and treatment of COVID-19. The immune responses to viral infection followed by cytokine storm and acute respiratory distress syndrome are serious issues that may cause death in patients with severe COVID-19. Therefore, developing a novel therapeutic strategy for the management of COVID-19 is urgently needed to control the virus spread and to improve the patient survival rate and clinical outcomes. In this mini-review, we summarize the symptoms, pathogenesis, and therapeutic approaches currently being used to manage the spread of SARS-CoV-2.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/1871526521666210301142223
2022-03-01
2024-11-16
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/1871526521666210301142223
Loading

  • Article Type:
    Review Article
Keyword(s): anosmia; COVID-19; diagnosis; pathogenesis; SARS-CoV-2; Viral infection
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test